Stay updated on Pembrolizumab with Radiation in Hodgkin Lymphoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab with Radiation in Hodgkin Lymphoma Clinical Trial page.

Latest updates to the Pembrolizumab with Radiation in Hodgkin Lymphoma Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedNew page sections were added: No longer looking for participants, How to Read a Study Record, Common Questions, and How to Join a Study. The Intervention/Treatment header was added and the previous Intervention / Treatment header removed; the site revision tag updated from v3.5.5 to v3.6.0.SummaryDifference0.4%

- Check17 days agoChange DetectedThe page revision metadata was updated to v3.5.5, replacing the previous v3.5.4. This indicates a minor update to the study record display.SummaryDifference0.1%

- Check39 days agoChange DetectedRevision updates were applied to the page, introducing new revision tags (v3.5.4) and prior version (v3.5.3) with associated dates. They reflect maintenance/version control rather than substantive changes to the trial details.SummaryDifference0.4%

- Check60 days agoChange DetectedThe ClinicalTrials.gov page’s revision/version identifier was updated from v3.5.2 to v3.5.3, indicating a site-side software/version change with no substantive changes to the study details.SummaryDifference0.1%

- Check67 days agoChange DetectedRevision: v3.5.2 updated from v3.5.0.SummaryDifference0.1%

- Check96 days agoChange DetectedRevision: v3.5.0 was added and Revision: v3.4.3 was removed.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab with Radiation in Hodgkin Lymphoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab with Radiation in Hodgkin Lymphoma Clinical Trial page.